1. Home
  2. NET vs RMD Comparison

NET vs RMD Comparison

Compare NET & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cloudflare Inc.

NET

Cloudflare Inc.

HOLD

Current Price

$197.51

Market Cap

68.1B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$202.55

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NET
RMD
Founded
2009
1989
Country
United States
United States
Employees
5483
10600
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.1B
29.4B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
NET
RMD
Price
$197.51
$202.55
Analyst Decision
Buy
Buy
Analyst Count
25
10
Target Price
$236.72
$292.56
AVG Volume (30 Days)
4.1M
1.3M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
1.13%
EPS Growth
58.18
N/A
EPS
N/A
N/A
Revenue
$1,669,626,000.00
N/A
Revenue This Year
$30.49
$10.60
Revenue Next Year
$27.50
$7.41
P/E Ratio
N/A
$25.61
Revenue Growth
28.76
N/A
52 Week Low
$154.03
$198.61
52 Week High
$260.00
$293.81

Technical Indicators

Market Signals
Indicator
NET
RMD
Relative Strength Index (RSI) 45.82 34.47
Support Level $187.01 $198.64
Resistance Level $218.51 $260.21
Average True Range (ATR) 11.95 5.21
MACD -3.50 -0.29
Stochastic Oscillator 15.88 17.04

Price Performance

Historical Comparison
NET
RMD

About NET Cloudflare Inc.

Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, builds on this infrastructure by enabling clients to deploy and run code without the need to manage or maintain servers.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: